Group 1: New Stock Offerings - Two new stocks will be available for subscription on the Sci-Tech Innovation Board next week: Moer Thread on November 24 and Bai Ao Sai Tu on November 28 [1] - Moer Thread's offering price is set at 114.28 yuan per share, making it the highest IPO price this year, with a total fundraising target of 8 billion yuan [1][2] - Moer Thread is expected to become the "first domestic GPU stock" upon listing, with a total market capitalization projected to reach 53.7 billion yuan [2] Group 2: Moer Thread Company Overview - Moer Thread focuses on the research, design, and sales of GPUs and related products, aiming to provide computing acceleration platforms for high-performance computing fields such as AI and digital twins [2] - The company has launched four generations of GPU architectures since its establishment in 2020, but has not yet achieved profitability, reporting losses from 2022 to 2025 [2] Group 3: Bai Ao Sai Tu Company Overview - Bai Ao Sai Tu is a leading company in the field of model animals, focusing on preclinical research and biotechnology services [3] - The company utilizes its proprietary gene editing technology to provide innovative model animals and drug development services, and has been listed in Hong Kong since 2022 [3] - Bai Ao Sai Tu has shown revenue growth from 5.34 billion yuan in 2022 to an expected 9.80 billion yuan in 2024, with a net profit turning positive in 2025 [3]

证券研究报告 | 2025年11月17日 金融工程日报 沪指震荡下跌，锂矿题材逆势爆发 核心观点 金融工程日报 市场表现：今日(20251117) 规模指数中中证 2000 指数表现较好，板块指数 中北证 50 指数表现较好，风格指数中中证 500 价值指数表现较好。计算机、 国防军工、煤炭、基础化工、房地产行业表现较好，医药、银行、非银、建 材、电新行业表现较差。锂矿、两岸融合、盐湖提锂、操作系统、水产等概 念表现较好，CRO、创新药、CAR-T 疗法、猴痘、疫苗等概念表现较差。 市场情绪：今日市场情绪较为高涨，收盘时有 100 只股票涨停，有 13 只股 票跌停。昨日涨停股票今日收盘收益为 2.47%，昨日跌停股票今日收盘收益 为-2.56%。今日封板率 76%，较前日提升 10%，连板率 36%，较前日提升 6%。 市场资金流向：截至 20251114 两融余额为 24927 亿元，其中融资余额 24747 亿元，融券余额 180 亿元。两融余额占流通市值比重为 2.5%，两融交易占市 场成交额比重为 10.0%。 折溢价：20251114 当日 ETF 溢价较多的是创科技 ETF，ETF 折价较多的是 ...

Core Viewpoint - The article discusses the recent performance and business operations of Haiprime, highlighting its position in the pharmaceutical industry and the impact of currency depreciation on its revenue [2][3]. Company Overview - Haiprime, established in 1998 and headquartered in Shenzhen, is a leading multinational pharmaceutical company with A+H dual financing platforms, focusing on the heparin industry chain, biopharmaceutical CDMO, and innovative drug development [2][7]. - The company's main revenue sources include formulations (63.06%), CDMO services (18.59%), and heparin sodium and low molecular weight heparin raw materials (16.05%) [7]. Financial Performance - For the period from January to September 2025, Haiprime reported a revenue of 4.194 billion yuan, representing a year-on-year growth of 3.09%, while the net profit attributable to shareholders decreased by 29.04% to 554 million yuan [7]. - As of September 30, 2025, the overseas revenue accounted for 93.04% of total revenue, benefiting from the depreciation of the Chinese yuan [3]. Market Activity - On November 17, Haiprime's stock price fell by 1.67%, with a trading volume of 49.2036 million yuan and a turnover rate of 0.32%, bringing the total market capitalization to 18.121 billion yuan [1]. - The stock has seen a net inflow of 1.2514 million yuan from major investors today, with no significant trend in buying or selling observed [4][5]. Technical Analysis - The average trading cost of Haiprime's shares is 11.59 yuan, with the stock price approaching a resistance level of 12.41 yuan, indicating potential for a price correction if it fails to break through this level [6]. Dividend Information - Since its A-share listing, Haiprime has distributed a total of 4.21 billion yuan in dividends, with 514 million yuan distributed over the past three years [8]. Shareholder Structure - As of September 30, 2025, Haiprime had 27,000 shareholders, with the Hong Kong Central Clearing Limited being the eighth largest shareholder, holding 12.0093 million shares, an increase of 691,700 shares from the previous period [9].

Core Viewpoint - The company, Baihua Pharmaceutical, has shown a significant increase in stock price and financial performance, indicating a stable growth trajectory in the CRO (Contract Research Organization) sector. Group 1: Financial Performance - As of November 14, 2025, Baihua Pharmaceutical's stock closed at 9.85 yuan, up 9.93% from the previous week, with a market capitalization of 3.788 billion yuan [1] - For the third quarter of 2025, the company reported a net profit increase of 36.41% year-on-year, attributed to enhanced project management and cost control [10] - The operating cash flow for Q3 increased by 168.61% year-on-year due to improved sales collection and cost management [7][10] Group 2: Business Operations - The company achieved an operating revenue of 299 million yuan in Q3 2025, reflecting a year-on-year growth of 2.74%, with a net profit of 32.67 million yuan, up 36.41% [2] - Baihua Pharmaceutical's main business includes early drug discovery, drug CMC development, clinical trials, and various analytical services, providing a comprehensive outsourcing and technology transfer service [5] - The company has a strong focus on complex formulations, with 89 projects filed and 52 approved in the first half of 2025, marking a 32.84% increase in project filings [3] Group 3: Competitive Strategy - To address increasing competition in the CRO industry, the company employs a differentiated strategy by leveraging its expertise in complex formulations to create high technical barriers [4] - The company emphasizes full-cycle management to enhance service efficiency and reduce overall costs for clients [4] - Baihua Pharmaceutical aims to improve profitability through sales strategies, cost control, and incentive mechanisms [6]

Market Overview - The A-share market experienced fluctuations, with the Shanghai Composite Index down by 0.25%, the Shenzhen Component Index down by 0.36%, and the ChiNext Index down by 0.51% as of the close [3][4]. - The total trading volume in the Shanghai and Shenzhen markets was 2 trillion yuan, a decrease of 56.2 billion yuan compared to the previous trading day, with over 3,100 stocks declining [7]. Sector Performance - The computing hardware and software sectors led the decline, with significant drops in server, DeepSeek, and fintech indices. Conversely, chemical stocks surged, particularly in fluorine and phosphorus chemical sectors, while solid-state battery themes gained strength [6]. - Major capital inflows were observed in basic chemicals, photovoltaic equipment, and energy metals, while there were notable outflows from computing, electronics, and power grid equipment sectors [9]. Individual Stock Movements - Specific stocks that saw net inflows included Tianfu Communication (22.32 billion yuan), Tianci Materials (9.66 billion yuan), and Duofluor (8.65 billion yuan) [10]. - Stocks that faced significant net outflows included Industrial Fulian (21.42 billion yuan), Sanhua Intelligent Control (15.36 billion yuan), and Silis (8.87 billion yuan) [11]. Institutional Insights - Longcheng Securities noted that the market has entered a quiet period in November, lacking major policy or event-driven catalysts, suggesting that market movements will rely more on technical and fundamental support [12]. - Huaxi Securities indicated that following the release of Q3 reports, the A-share market is entering a performance vacuum period of about three months, shifting focus towards next year's performance expectations and industry trends, with trading likely returning to active themes [12].

Market Overview - The Asia-Pacific stock markets experienced a collective decline influenced by the "Black Tuesday" in the US stock market, but the A-shares showed an independent trend with all three major indices closing higher. The Shanghai Composite Index rose by 0.23% to 3969 points, the Shenzhen Component Index increased by 0.37%, and the ChiNext Index gained 1.03% [1]. Trading Volume and Market Activity - The total market turnover reached 1.89 trillion yuan, a decrease of 441 billion yuan compared to the previous trading day, with nearly 3400 stocks rising [1]. Sector Performance - The Hainan sector was notably active, with stocks like Haima Automobile and Haixia Shares hitting the daily limit. The State Grid completed fixed asset investments exceeding 420 billion yuan, leading to gains in the electric grid equipment, ultra-high voltage, and smart grid sectors, with stocks such as Jinguan Electric and TBEA also hitting the daily limit [1]. - The titanium dioxide sector saw a surge, with Vanadium Titanium Shares hitting the daily limit. The photovoltaic equipment sector also performed well, with Aters hitting a 20% increase limit. Other sectors with significant gains included duty-free concepts, high-speed charging, energy storage, and wind power equipment [1]. Declining Sectors - The recombinant protein sector declined, with Sanofi falling over 8%. The quantum technology sector also saw a drop, with Keda Guokai decreasing by over 7%. Other sectors that experienced significant declines included Kimi concept, data security, digital currency, and CRO [1]. Top Gainers - The top gainers included sectors such as forestry, power generation equipment, and electrical grid, with respective increases of 3.88%, 1.68%, and 3.43% [2].

Market Overview - The A-share market saw a majority of the major indices decline today, with the Shanghai Composite Index down by 0.41% closing at 3960.19 points, the Shenzhen Component down by 1.71% at 13175.22 points, and the ChiNext Index down by 1.96% at 3134.09 points [1][10] - Overall, there were 1627 stocks that rose and 3646 stocks that fell, with a total trading volume of 19158 billion yuan, a decrease of 1913 billion yuan compared to the previous trading day [1] Industry Performance - Most of the Shenwan first-level industries experienced declines, with only the banking, public utilities, social services, environmental protection, and textile and apparel sectors showing gains, increasing by 2.03%, 0.24%, 0.15%, 0.15%, and 0.07% respectively [1] - The sectors that led the decline included non-ferrous metals, electric equipment, pharmaceutical biology, beauty care, and basic chemicals, with declines of 3.04%, 2.05%, 1.97%, 1.74%, and 1.57% respectively [1] Concept Sector Performance - The concept sectors that performed well today included continuous boards, hit boards, first boards, banking, duty-free shops, high send-off, ultra-high voltage, insurance, Hainan Free Trade Port, film and television, vaccines, electricity, blood products, ST stocks, and rare earths [2] - Conversely, sectors such as CRO, industrial metals, and equity incentives saw a decline [12]

Market Overview - The A-share market experienced a collective decline, with the Shanghai Composite Index falling by 0.41% to 3960 points, the Shenzhen Component Index dropping by 1.71%, and the ChiNext Index decreasing by 1.96% [1][2] - The total market turnover was 1.94 trillion yuan, a decrease of 194.5 billion yuan compared to the previous trading day, with over 3600 stocks declining [1] Index Performance - Shanghai Composite Index: 3960.19, down 16.33 points (-0.41%) [2] - Shenzhen Component Index: 13175.22, down 228.84 points (-1.71%) [2] - ChiNext Index: 6305.90, down 62.78 points (-1.96%) [2] - Other indices such as the CSI 300 and CSI 500 also showed declines of 0.75% and 1.67% respectively [2] Sector Performance - The precious metals sector continued to adjust, with Zhongjin Gold (600489) falling over 5% [3] - Lithium mining concepts declined, with Guocheng Mining (000688) nearing a trading halt [3] - The robotics sector weakened, with Strong瑞 Technology dropping nearly 10% [3] - Other sectors with significant declines included PEEK materials, CRO, innovative drugs, and motors [3] Notable Stocks and Sectors - The banking sector was active, with Xiamen Bank leading the gains [3] - The ice and snow economy sector saw an increase, with Dalian Shengya (600593) hitting the daily limit [3] - The Fujian sector surged against the market trend due to new immigration policies, with nearly 20 stocks including Zhaobiao Co. and Zhongneng Electric (300062) reaching the daily limit [3] - Sectors such as lottery concepts, tourism hotels, and power grid equipment showed notable gains [3]

Market Performance - The three major A-share indices collectively declined, with the Shanghai Composite Index down 0.41% to 3960 points, the Shenzhen Component Index down 1.71%, and the ChiNext Index down 1.96% [1] - The total market turnover was 1.94 trillion yuan, a decrease of 194.5 billion yuan compared to the previous trading day, with over 3600 stocks declining [1] Sector Performance - The precious metals sector continued to adjust, with Zhongjin Gold falling over 5% [1] - Lithium mining concepts weakened, with Guocheng Mining nearing a limit down [1] - The robotics sector also weakened, with Strong瑞 Technology dropping nearly 10% [1] - Other sectors with significant declines included PEEK materials, CRO, innovative drugs, and electric motors [1] Notable Movements - The Fujian sector surged against the market trend due to the implementation of 10 immigration and exit-entry management service policies by the National Immigration Administration, with nearly 20 stocks such as Zhaobiao Co., Zhongneng Electric, and Fulongma hitting the daily limit [1] - Bank stocks were active, with Xiamen Bank leading the gains [1] - The ice and snow economy sector rose, with Dalian Shengya hitting the daily limit [1] - Other sectors with notable gains included lottery concepts, tourism hotels, and power grid equipment [1] Top Gainers and Fund Flows - The top gainers included the forestry sector (+2.51%), catering and tourism (+1.26%), and banking (+2.09%) in terms of net capital inflow [2] - The five-day gainers included the highway sector (+1.309) and environmental protection [2]

Market Overview - The A-share market experienced a decline in the morning session, with the Shanghai Composite Index down 0.19%, the Shenzhen Component down 1.27%, and the ChiNext Index down 1.51% [1][2] - The total trading volume in the Shanghai and Shenzhen markets was 1.22 trillion yuan, a decrease of 164.8 billion yuan compared to the previous trading day [2] Sector Performance - The banking sector showed strong performance, with all bank stocks rising, while gold stocks continued to decline and innovative drug concept stocks fell [1][12][15] - The banking sector saw significant gains, with major banks like China Merchants Bank up 2.92% and Industrial Bank up over 3% [5][6] Banking Sector Highlights - Major banks reported positive stock performance, with Agricultural Bank of China at 2.00% increase, Industrial and Commercial Bank of China at 2.53%, and China Merchants Bank at 2.92% [6][7] - The total market capitalization of Agricultural Bank of China is 2779.2 billion yuan, while Industrial and Commercial Bank of China stands at 2679.2 billion yuan [6] Insurance Sector Performance - The insurance sector also saw positive movement, with major companies like China Life and New China Life both increasing by over 1% [8][9] - The five major A-share listed insurance companies reported a total revenue of 23,739.81 billion yuan, a year-on-year increase of 13.6%, and a net profit of 4,260.39 billion yuan, up 33.5% [9] Gold Sector Decline - The gold sector faced a collective downturn, with companies like Shengda Resources down over 5% and Zhongjin Gold down over 3% [12][13] - The current price of gold jewelry in some brands has increased, with prices reported at 1265 yuan per gram [13] Innovative Drug Sector Decline - The innovative drug sector experienced significant declines, with companies like Heng Rui Medicine down over 1.15% [15][18] - The recent national medical insurance negotiations introduced a new mechanism for high-value innovative drugs, which may alleviate payment pressures through commercial insurance channels [18]